title: Clinical usefulness of blood metal measurements to assess the failure of metal-on-metal hip implants.
abstract: In April 2010, a Medicines and Healthcare Products Regulatory Agency safety alert concerning all metal-on-metal (MOM) hip replacements recommended measuring chromium and cobalt concentrations when managing patients with painful prostheses. The need for this review is illustrated by the recent surge in requests for these blood tests from orthopaedic surgeons following this alert. The aim is to provide guidance to laboratories in assessing these requests and advising clinicians on interpretation. First, we summarize the basic terminology regarding the types of hip replacements, with emphasis on the MOM type. Second, we describe the clinical concerns over implant-derived wear debris in the local tissues and distant sites. Analytical aspects of the measurement of the relevant metal ions and what factors affect the levels measured are discussed. The application of inductively coupled plasma mass spectrometry techniques to the measurement of these metals is considered in detail. The biological effects of metal wear products are summarized with local toxicity and systemic biological effects considered, including carcinogenicity, genotoxicity and systemic toxicity. Clinical cases are used to illustrate pertinent points.
authors.affiliation: Department of Clinical Biochemistry, Charing Cross Hospital, Imperial College Healthcare NHS Trust, Fulham Palace Road, London, UK. b.sampson@imperial.ac.uk
authors.forename: Barry
authors.initials: B
authors.lastname: Sampson
authors.forename: Alister
authors.initials: A
authors.lastname: Hart
mesh_terms: D006622:Hip Prosthesis; D006801:Humans; D008670:Metals / Q000097:blood*
chemical_list: D008670:Metals